INELIGIBLE SITES: Head and neck, visceral organs (with the exception of embryonal sarcoma of the liver), retroperitoneum, peritoneum, pelvis within the confines of the bony pelvis
MRI of pelvis within  days prior to registration
Have a history of prior radiotherapy to the whole pelvis.
Radiation to spine/pelvis bone or chemoradiation to pelvic organs
History of radiation to the pelvis
Prior radiation therapy to the prostate or lower pelvis encompassing the prostate
Have received prior radiotherapy of the mediastinal/pericardial area or whole pelvis radiation.
Prior radiation to the pelvis.
No prior radiotherapy to the prostate or lower pelvis
Prior radiation therapy to the pelvis
Prior radiation of any kind to the prostate gland or pelvis\r\n* Prior brachytherapy is not allowed
Patients with metastatic disease outside of the pelvis
Prior radiation therapy to the pelvis
No prior radiotherapy to the prostate or lower pelvis
Prior radiation treatment to the pelvis
Patients with localized sarcomas that are not of the extremity or trunk wall (including head/neck, retroperitoneum, visceral organs, peritoneum, pelvis within the confines of the bony pelvis, and tumors arising in bone)
Prior radiation therapy to the pelvis
Prior radiation therapy to whole pelvis or greater amount of marrow-forming bone
 weeks if prior craniospinal chemoradiation therapy (CRT) or if ? % radiation of pelvis.
Prior history of radiation to the pelvis
Previous radiation therapy to the pelvis.
Prior radiotherapy of the mediastinal/pericardial area or whole pelvis radiation.
Prior radiation treatment of >  gray (Gy) to the pelvis
Radiation including large bone marrow fields such as sternum or pelvis within  weeks prior to leukapheresis
Prior radiation to greater than % of the bone marrow or whole pelvis radiation
Study-specific exclusions:\r\n* History of prior radiation to the pelvis\r\n* History of uncontrolled inflammatory bowel disease\r\n* Unable to comply with radiation therapy procedures
Prior radiation to greater than % of the bone marrow or whole pelvis radiation
Women with prior radiotherapy to the pelvis or retroperitoneal surgery
Women with metastatic disease outside of pelvis
Concurrent use of other anti-cancer agents or treatment or concurrent radiation to the pelvis; palliative radiation to areas outside the pelvis is allowed
Prior radiation to the liver (prior radiation therapy to the pelvis is acceptable if completed at least  weeks prior to registration)
Prior radiotherapy to the pelvis
No prior radiation therapy to the whole pelvis or to ?% of the total bone marrow area.
Have had prior dissection and/or radiation in pelvis.
Prior radiation to the liver (prior radiation therapy to the pelvis is acceptable if completed at least  weeks prior to registration)
Previous radiation therapy is allowed to less than % of the bone marrow, but should have been limited and must not have included whole pelvis radiation.
Radiation treatment to pelvis
Prior radiotherapy to the pelvis or prostate
Patients who have previously undergone radiation treatment to the pelvis
Patients who have had prior radiation to the pelvis
Patients with no prior radiation therapy to the pelvis
Metastatic disease outside of pelvis on any imaging or biopsy
Previous radiation treatment of the pelvis
A working diagnosis of malignancy in the liver, brain, H&N, or pelvis